SciELO - Scientific Electronic Library Online

 
vol.79 número6Comparación de las medidas de la papila obtenidas con biomicroscopia y con oftalmoscopia de láser confoncalEstrés oxidativo en un modelo de retinopatía diabética experimental: tratamiento con antioxidantes índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Archivos de la Sociedad Española de Oftalmología

versão impressa ISSN 0365-6691

Resumo

ALVAREZ SUAREZ, ML et al. Collagenase-3 (MMP-13) expression in epithelial cancers of the eyelids. Arch Soc Esp Oftalmol [online]. 2004, vol.79, n.6, pp.281-288. ISSN 0365-6691.

Purpose: To determine, by means of immunohistochemistry, tumoral expression of collagenase-3, a matrix metalloproteinase linked to cancer and to basal cell and squamous cell carcinomas of the eyelid. Material and method: Retrospective review of 23 basal cell carcinomas and 25 squamous cell carcinomas of the eyelid treated at different hospitals during the last five years. We evaluated collagenase-3 expression and the possible relationship to patient and tumour characteristics which included age, sex, histological type, tumour location and surgical margins status. Results: 65% of the basal cell carcinomas and 88% of the squamous cell carcinomas of the eyelids stained positively for collagenase-3. In both cases, the immunostaining was localized in the cytoplasm of the malignant cells and, occasionally in the surrounding stromal cells. Conclusions: Statistical analysis showed no significant association between collagenase-3 immunostaining and patients or tumour characteristics but the expression of this protein was more intense in the epithelial tumoral cells located at the invading front which could explain the aggressive behaviour of this kind of tumours.

Palavras-chave : Collagenase-3; matrix metalloproteinase-13; basal cell carcinoma; squamous cell carcinoma; eyelid.

        · resumo em Espanhol     · texto em Espanhol

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons